YARRA THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Jun 2020)
What this means for you
This application is over — abandoned 22 Jun 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87826260
- Mark type
- Stylized text
- Filed
- 08 Mar 2018
- Published for opposition
- 25 Sept 2018
- Abandoned
- 22 Jun 2020
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma
- Class 042 — Scientific and technological services: Pharmaceutical research and development; laboratory research services relating to pharmaceuticals
Owner
- Array Biopharma Inc., Boulder, CO, US
- Array Biopharma Inc., Boulder, CO, US
Prosecution history
- 22 Jun 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Jun 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 04 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 May 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 May 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 May 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 May 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 25 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Oct 2019 — SOU EXTENSION 2 GRANTED
- 23 Oct 2019 — SOU EXTENSION 2 FILED
- 23 Oct 2019 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Apr 2019 — SOU EXTENSION 1 GRANTED
- 09 Apr 2019 — SOU EXTENSION 1 FILED
- 09 Apr 2019 — SOU TEAS EXTENSION RECEIVED